The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden

The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden Review Abstract Lipidology is undergoing a clinically important transition from traditional cholesterol-centered assessment toward a more precise evaluation of atherogenic lipoprotein burden. Low-density lipoprotein cholesterol (LDL-C) remains a validated therapeutic target

Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?

Cholesterol Guidelines 2025: Should Age 40 Be the New Threshold for Statin Therapy?   Introduction Cardiovascular disease (CVD) remains the leading cause of death for most racial and ethnic groups, with cholesterol guidelines playing a crucial role in prevention strategies. Dyslipidemia stands

The Rise of Precision Lipidology: Beyond LDL-C to ApoB, Lp(a), and Atherogenic Particle Burden